Dengan keterbatasan bukti yang ada, perkembangan siapa saja yang boleh diberikan vaksin COVID-19 terus berkembang. Salah satunya adalah rekomendasi dari Thalassemia International Federation yang baru saja mengeluarkan rekomendasinya. Seperti apa sih? Singkatnya adalah, seluruh pasien Thalassemia, baik yang minor, intermedia, maupun yang mayor bisa divaksin. Untuk yang mayor, dengan beberapa kriteria yang termasuk kategori berat, maka tetap harus ditawari untuk vaksinasi. Tentunya setelah dijelaskan keuntungan dan resikonya. Berikut adalah statement dari TIF:

TIF’s ‘Thalassaemia & Sickle Cell Disease Classification of Risk Groups Guidance’
27 as previously
mentioned offers a gross but hopefully useful stratification of risk levels for patients with haemoglobin
disorders. This can offer significant guidance on which patients need to be vaccinated in the first
phases, followed by others in second and third phases of the vaccination programmes offered to
vulnerable populations.
Having described this proposed sequence of the vaccination process, the treating physician has the
responsibility of acknowledging any allergies the patient is known to have, and/or levels of
immunosuppression related to drug treatment that the patient is currently undergoing or has recently
undergone. The comprehensive knowledge of the clinical status of each patient is borne by each
patients’ treating physician.
In addition, it should be noted that the patients meeting the following criteria, should be offered the
vaccine as soon as possible, as suggested by the UK Haemoglobinopathy Panel28:

  1. All adults with SCD
  2. Thalassaemia patients with severe iron overload
  3. Splenectomized patients
  4. Patients will 1 or more underlying co-morbidities including diabetes, pulmonary hypertension,
    endocrine, cardiac, respiratory disease
    Moreover, acknowledging that each disorders’ nature, genetic background, and pathophysiology is
    complex and heterogenous, a personalized decision for each patient separately is required to be taken
    by the treating physician concerning a possible vaccination against SARS-CoV-2.